These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36381832)

  • 1. Knowledge and Attitude of Sudanese Emergency Registrars Towards the Use of Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke.
    Ahmed HJ; Yassin R; Yassin D; Elkhidir I
    Cureus; 2022 Oct; 14(10):e29908. PubMed ID: 36381832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.
    Tanne D; Gorman MJ; Bates VE; Kasner SE; Scott P; Verro P; Binder JR; Dayno JM; Schultz LR; Levine SR
    Stroke; 2000 Feb; 31(2):370-5. PubMed ID: 10657408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
    Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
    Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Thrombolysis Process for Acute Ischemic Stroke in Urban and Rural Hospitals in Nova Scotia Canada.
    Bulmer T; Volders D; Kamal N
    Front Neurol; 2021; 12():645228. PubMed ID: 33790851
    [No Abstract]   [Full Text] [Related]  

  • 10. Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey.
    Grady AM; Bryant J; Carey ML; Paul CL; Sanson-Fisher RW; Levi CR
    BMC Res Notes; 2015 Jun; 8():267. PubMed ID: 26111807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.
    Martin-Schild S; Hallevi H; Albright KC; Khaja AM; Barreto AD; Gonzales NR; Grotta JC; Savitz SI
    Arch Neurol; 2008 Sep; 65(9):1174-8. PubMed ID: 18779419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.
    Scott PA; Xu Z; Meurer WJ; Frederiksen SM; Haan MN; Westfall MW; Kothari SU; Morgenstern LB; Kalbfleisch JD
    Stroke; 2010 Sep; 41(9):2026-32. PubMed ID: 20705931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
    Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
    Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social History Matters-The Impact of Illicit Drug Use on tPA Use and In-Hospital Mortality in Acute Ischemic Stroke.
    Marx MH; Albright KC; Shaban A; Boehme AK; Beasley TM; Martin-Schild S
    Int Neuropsychiatr Dis J; 2014 May; 2(3):127-135. PubMed ID: 25436216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke.
    Al Khathaami AM; Aloraini H; Almudlej S; Al Issa H; Elshammaa N; Alsolamy S
    Neurol Res Int; 2018; 2018():3050278. PubMed ID: 30364030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Smartphone Platform to Help With Emergency Management of Acute Ischemic Stroke: Observational Study.
    Wu Y; Chen F; Song H; Feng W; Sun J; Liu R; Li D; Liu Y
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e25488. PubMed ID: 33560236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stop Stroke: A Brief Report on Door-to-Needle Times and Performance After Implementing an Acute Care Coordination Medical Application and Implications to Emergency Medical Services.
    Dickson R; Nedelcut A; Nedelcut MM
    Prehosp Disaster Med; 2017 Jun; 32(3):343-347. PubMed ID: 28219452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of geographical factors with administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Morishima T; Ukawa N; Ikai H; Otsubo T; Ishikawa KB; Yokota C; Minematsu K; Fushimi K; Imanaka Y
    J Am Heart Assoc; 2013 Sep; 2(5):e000336. PubMed ID: 24045119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke.
    Chalela JA; Kasner SE; Jauch EC; Pancioli AM
    Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.